The following table summarizes key financial highlights associated with the Company’s financial performance.
|September 30, 2019
|September 30, 2018
|Total Shareholders’ Equity||3,016||3,792|
In conjunction with this approval, effective November 27, 2019 the Company issued a total of 5,500,000 options to officers and directors of the Company with an exercise price of $0.05. These options are fully vested and expire on November 27, 2024. This grant is subject to final regulatory and shareholder approval.
For additional information please contact: